방선균증을 동반한 약물 관련 악골괴사증 (MRONJ): 증례보고
Medication-Related Osteonecrosis of the Jaw (MRONJ) Associated with Actinomycosis: Two Case Reports
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
These are two case reports of Medication-Related Osteonecrosis of the Jaw (MRONJ) associated with Actinomycosis in the mandible. Actinomycosis is a chronic, extensive granulomatous, bacterial infection and the most commonly found microorganism is Actinomyces israelii. Medication-related Osteonecrosis of the Jaw (MRONJ) is a complication of antiresorptive and antiangiogenic drugs. There are 2 cases in these reports representing Medication-related Osteonecrosis of the Jaw (MRONJ) clinically and Actinomycosis pathologically. After the surgical and antibiotic treatments, these cases show favorable responses. In this study, we could take into consideration that Actinomycosis is related to the pathogenesis of Medication-related Osteonecrosis of the Jaw (MRONJ).
Abstract
These are two case reports of Medication-Related Osteonecrosis of the Jaw (MRONJ) associated with Actinomycosis in the mandible. Actinomycosis is a chronic, extensive granulomatous, bacterial infection and the most commonly found microorganism is Actinomyces israelii. Medication-related Osteonecrosis of the Jaw (MRONJ) is a complication of antiresorptive and antiangiogenic drugs. There are 2 cases in these reports representing Medication-related Osteonecrosis of the Jaw (MRONJ) clinically and Actinomycosis pathologically. After the surgical and antibiotic treatments, these cases show favorable responses. In this study, we could take into consideration that Actinomycosis is related to the pathogenesis of Medication-related Osteonecrosis of the Jaw (MRONJ).
참고문헌 (22)
- Marx RE, "Pamidronate(Aredia)and zoledronate(Zometa)induced avascular necrosis of the jaws : a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
- Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update", J Oral Maxillofac Surg, 72, pp.1938~1956 (2014)
- Moghimi M, "Treatment of cervicofacial actinomycosis : a report of 19 cases and review of literature", Med Oral Patol Oral Cir Bucal, 18, pp.e627~32 (2013)
- Steininger C, "Resistance patterns in clinical isolates of pathogenic Actinomyces species", J Antimicrob Chemother, 71, pp.422~427 (2016)
- Sezer B, "Actinomycosis osteomyelitis of the jaws : Report of four cases and a review of the literature", J Dent Sci, 12, pp.301~307 (2017)
- Robbins SL, "Pathologic basis of disease, Infectious disease", pp.349~350 (1984), WB Sauders Co
- Fliefel R, "Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw(BRONJ)with characterization of patients : a systematic review", Int J Oral Maxillofac Surg, 44, pp.568~585 (2015)
- Estilo CL, "Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy", Oncologist, 13, pp.911~920 (2008)
- Bennhoff DF, "Actinomycosis : Diagnostic and therapeutic considerations and a review of 32 cases", Laryngoscope, 94, pp.1198~1217 (1984)
- Boyanova L, "Actinomycosis : a frequently forgotten disease", Future Microbiol, 10, pp.613~628 (2015)
- Fradis M, "Actinomycosis of the face and neck", Arch Otolaryngol, 102, pp.87~89 (1976)
- Martin MV, "The use of oral amoxycillin for the treatment of actinomycosis. A clinical and in vitro study", Br Dent J, 156, pp.252~254 (1984)
- Lad SD, "Cranio-facial actinomycosis", Br J Neurosurg, 5, pp.361~370 (1991)
- Lerner PO, "Susceptibility of pathologic actinomycetes to antimicrobial compounds", Antimicrob Agents Chemothe, 5, pp.302~ (1974)
- Russmueller G, "The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection", Sci Rep, 6, pp.31604~ (2016)
- Bisdas S, "Biphosphonate-induced osteonecrosis of the jaws : CT and MRI spectrum of findings in 32 patients", Clin Radiol, 63, pp.71~77 (2008)
- Hansen T, "Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis", Virchows Arch, 451, pp.1009~1017 (2007)
- Bilezikian JP, "Osteonecrosis of the jaw-do bisphosphonates pose a risk?", N Engl J Med, 355, pp.2278~2281 (2006)
- Gomez Font R, "Osteochemonecrosis of the jaws due to bisphosphonate treatments", Med Oral Patol Oral Cir Bucal, 13, pp.e318~e324 (2008)
- Migliorati CA, "Bisphosphonate-associated osteonecrosis : a long-term complication of bisphosphonate treatment", Lancet Oncol, 7, pp.508~514 (2006)
- Naik NH, "Bisphosphonate-related osteonecrosis of the jaw : the role of actinomyces", Clin Infect Dis, 49, pp.1729~1732 (2009)
- Cerrato A, "Actinomyces and MRONJ : A retrospective study and a literature review", J Stomatol Oral Maxillofac Surg, (20), pp.30175~ (2020)